Linda J Harrison

9PUBLICATIONS
21CO-AUTHORS
Epidemiological methodsPredictive and prognostic markersPharmacogenomicsMajor global burdens of diseaseLarge and complex data theory
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 18, 2026
Proportional Odds or Win Probability as Methods for Assessing Ordinal Outcomes in Infectious Disease Clinical Trials.

|Apr 16, 2026
Tuberculosis Disease Severity Assessment Using Clinical Variables and Radiology Enabled by Artificial Intelligence.

|Aug 15, 2025
ACTG A5409 (RAD-TB): Study protocol for a phase 2 randomized, adaptive, dose-ranging, open-label trial of novel regimens for the treatment of pulmonary tuberculosis.

Linda J Harrison, Gustavo E Velásquez, Russell R Kempker

|Aug 12, 2025
The Wilcoxon-Mann-Whitney Estimand Versus Differences in Medians or Means.

Linda J Harrison, Ronald J Bosch

|Apr 08, 2025
ACTG A5409 (RAD-TB): Study Protocol for a Phase 2 Randomized, Adaptive, Dose-Ranging, Open-Label Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis.

Linda Harrison, Gustavo E Velasquez, Russell R Kempker

|Feb 17, 2025
Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial.

Anne F Luetkemeyer, Kara W Chew, Stuart Lacey

Pageof 2

Frequent Collaborators

2 joint publications

Rui Wang

1 joint publications

Marwan Ghanem

1 joint publications

Yasha Ektefaie

1 joint publications

Ziv Yaniv